Trial intelligence / Profile preview

Evicel in Total Knee Replacement

NCT01235715Phase 4Completed

Sponsor
Hospital for Special Surgery
Start
Sep 2010
Primary completion
Mar 2012
Modality
Biologic
Countries
1
01

Overview

Phase 4, randomised, open-label trial of porcine fibrin sealant (2 arms), sponsored by Hospital for Special Surgery. Primary endpoints: Change in Hemoglobin at Day 2, Change in Hematocrit at Day 2 and 3 more. Started Sep 2010; status: completed.

02

Drugs

porcine fibrin sealant

Beyond the preview

Go deeper on NCT01235715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01235715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call